AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2547137
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of hormone therapy
Trial: 27449404
Drug: Ramosetron (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramosetron (0.3 mg)
Trial: 23313969
Drug: Ramosetron plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramosetron plus Dexamethasone (8 mg + 0.3 mg)
Trial: 16761228
Drug: Tiotropium bromide
RxNorm normalized name: Tiotropium Bromide
DrugBank: Tiotropium (DB01409)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiotropium bromide 18 microg once daily
Trial: 9200849
Drug: TMB exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMB exposure and its metabolites in biological fluids.
Trial: 2888658
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg mifentidine
Trial: 26256990
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (ventilation with a tidal volume of 8 mL/kg)
Trial: 26256990
Drug: PEEP group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEEP group (ventilation with a tidal volume of 6 mL/kg and PEEP of 8 cm H₂O)
Trial: 16781225
Drug: Trimetazidine (TMZ)
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (TMZ) 40 mg TID
Trial: 9737645
Drug: Cerivastatin 0.4
RxNorm normalized name: cerivastatin 0.4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin 0.4 mg/day
Trial: 9737643
Drug: Cerivastatin 0.2
RxNorm normalized name: cerivastatin 0.2 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin 0.2 mg/day
Trial: 1207435
Drug: Caffeine (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (7 mg/kg)
Trial: 6131448
Drug: Crotylbarbital (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crotylbarbital (2 mg/kg)
Trial: 30782716
Drug: Automated oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automated oxygen administration (FreeO2 group)
Trial: 30782716
Drug: Conventional oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional oxygen therapy (Standard group)
Trial: 26773108
Drug: Brodalumab 280
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brodalumab 280 mg
Trial: 19902267
Drug: Combination steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination steroid and mizoribine (MZB) therapy (4-5 mg/kg/day)
Trial: 19902267
Drug: Steroid only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid only therapy
Trial: 30736770
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment (n = 25)
Trial: 26645159
Drug: Ultrasound-guided injection
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided injection (USGI) of corticosteroids (20mg of methylprednisolone acetate)
Trial: 26645159
Drug: Conventional blind
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional blind injection (CBI) of corticosteroids (20mg of methylprednisolone acetate)
Trial: 17920731
Drug: HIV‐1 DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV‐1 DNA vaccine
Trial: 16132246
Drug: Dietary therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary therapy alone (control group)
Trial: 11881315
Drug: Ibuprofen (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (400 mg) administered orally 12 and 2 hours before surgery, and every 8 hours until the third postoperative day.
Trial: 11881315
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no ibuprofen treatment).
Trial: 10225548
Drug: Sanguinarine toothpaste
RxNorm normalized name: sanguinarine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sanguinarine toothpaste and oral rinse
Trial: 10225548
Drug: Control toothpaste
RxNorm normalized name: Sodium Fluoride Dental Paste [TARTAR CONTROL TOOTHPASTE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control toothpaste and oral rinse without sanguinarine
Trial: 8942892
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (0.5 mg/ml)
Trial: 27920416
Drug: Intravenous pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pantoprazole 40 mg daily
Trial: 26905705
Drug: Mifepristone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone (200 mg) followed by vaginal misoprostol induction
Trial: 22160450
Drug: Both meals
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both meals (olive oil and cream)
Trial: 9864279
Drug: 21 mg/day
RxNorm normalized name: nicotine 21 MG/Day 24HR Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 21 mg/day transdermal nicotine
Trial: 9864279
Drug: 42 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 42 mg/day transdermal nicotine
Trial: 9864279
Drug: 63 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 63 mg/day transdermal nicotine
Trial: 8748047
Drug: lorazepam (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lorazepam (mean daily dose 4.2 mg)
Trial: 6118384
Drug: Prazosin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin (2 mg nebulized)
Trial: 28004320
Drug: Adjunctive brivaracetam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive brivaracetam
Trial: 19274788
Drug: Intravenous fluid
RxNorm normalized name: Intravenous fluid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous fluid
Trial: 10546710
Drug: Inpatient therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient therapy
Trial: 2512936
Drug: Intensive outpatient
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive outpatient therapy
Trial: 29512795
Drug: Inhaled nitrous
RxNorm normalized name: nitrous oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitrous oxide (MEOPA)
Trial: 15111138
Drug: High frequency
RxNorm normalized name: ALCOHOL 0.7 mL in 1 mL TOPICAL SOLUTION [enMotion Foam High Frequency Use]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High frequency exercise program (twice daily, including weekends)
Trial: 15111138
Drug: Low frequency
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low frequency exercise program (once daily, not on weekends)
Trial: 9054253
Drug: High-dose mivazerol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose mivazerol (1.5 micrograms.kg‐1.h‐1)
Trial: 9054253
Drug: Low-dose mivazerol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose mivazerol (0.75 microgram.kg‐1.h‐1)
Trial: 26385666
Drug: Standard fluid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard fluid therapy with supplementary intraoperative stroke volume optimization (mean 956 ml Gelofusine)
Trial: 18054930
Drug: Transdermal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen supplementation (100 microg/d)
Trial: 18054930
Drug: No transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No transdermal estrogen supplementation
Trial: 8818502
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment for primary site recurrence
Trial: 31280967
Drug: Adalimumab (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab (40 mg)
Trial: 31574261
Drug: 0.1-mL lavender
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1-mL lavender oil diffusion
Trial: 26779620
Drug: Spirulina maxima
RxNorm normalized name: SPIRULINA MAXIMA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirulina maxima supplementation (2 g daily for 3 months)
Trial: 22648340
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of mild exercise, hyperventilation, and normobaric hyperoxia (100% oxygen inhalation)
Trial: 16631880
Drug: bivalent HPV‐16/18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bivalent HPV‐16/18 virus‐like particle AS04 vaccine
Trial: 11083892
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment for chylous effusions
Trial: 1728708
Drug: Diclofenac, 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac, 75 mg intramuscularly twice daily
Trial: 7878629
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg recombinant tissue plasminogen activator (t‐PA)
Trial: 3071175
Drug: Preoperative continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative continuous nifedipine maintenance medication (10-20 mg p.o.)
Trial: 3071175
Drug: Nifedipine morning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine morning dose
Trial: 3071175
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (last nifedipine medication evening before surgery)
Trial: 28414485
Drug: Prolonged Exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged Exposure therapy with incentives (PE + I; max $480)
Trial: 3489270
Drug: bepridil (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bepridil (2 mg/kg)
Trial: 31581523
Drug: Inositol-enhanced arginine
RxNorm normalized name: Inositol
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inositol-enhanced arginine silicate oral supplement
Trial: 26279065
Drug: 1.4 g
RxNorm normalized name: MENTHOL 1.4 g in 100 g TOPICAL CREAM [Cetilar]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.4 g day-1 omega-3 polyunsaturated fatty acids (PUFAs) plus cognitive-behavioural case management (CBCM)
Trial: 23249829
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (ACE inhibitor ramipril + ARB telmisartan)
Trial: 23249829
Drug: Monotherapy (either
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (either ramipril or telmisartan)
Trial: 23249829
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy vs. monotherapy
Trial: 10966249
Drug: Iron group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron group (received 20 mg of iron saccharate intravenously daily for 14 days)
Trial: 10966249
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (received no additional therapy)
Trial: 8798250
Drug: Mean fasting
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mean fasting insulin levels
Trial: 1451070
Drug: Concurrent radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent radiation therapy (RT) with vinblastine
Trial: 28705783
Drug: Placebo (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (oral simethicone)
Trial: 10210990
Drug: High titre
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High titre vaccine (10(3.9) and 10(4.0) pfu)
Trial: 26214111
Drug: Focused education
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focused education and medication management intervention
Trial: 29775988
Drug: RT twice
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT twice a week (G2X)
Trial: 26738606
Drug: Neoadjuvant TAC
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neoadjuvant TAC chemotherapy with zoledronic acid
Trial: 26738606
Drug: Neoadjuvant TAC
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neoadjuvant TAC chemotherapy without zoledronic acid
Trial: 10778587
Drug: Hartone 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hartone 2 caps twice daily for 6 weeks and 1 cap twice daily for the next 6 weeks
Trial: 10778587
Drug: Isosorbide mononitrate
RxNorm normalized name: Isosorbide Mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide mononitrate (ISMN) 20 mg twice daily
Trial: 8176573
Drug: High-dose therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose therapy with corticotropin (ACTH) - 150 U/m2 per day for 3 weeks, 80 U/m2 per day for 2 weeks, 80 U/m2 every other day for 3 weeks, and 50 U/m2 per day every other day for 1 week, tapered to zero over 3 weeks.
Trial: 8176573
Drug: Low-dose therapy
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose therapy with corticotropin (ACTH) - 20 to 30 U/day for 2 to 6 weeks, tapered to zero over 1 week.
Trial: 2855105
Drug: Loperamide (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide (16 mg orally) + LVP (0.06 IU/kg i.v. over 1 h)
Trial: 2855105
Drug: Loperamide (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide (16 mg orally) + Placebo + LVP (0.06 IU/kg i.v. over 1 h)
Trial: 2855105
Drug: Loperamide (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide (16 mg orally) + CRH (1 micrograms/kg i.v. as bolus)
Trial: 23839175
Drug: Adapalene 0.1%-benzoyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adapalene 0.1%-benzoyl peroxide 2.5% gel (adapalene-BPO)
Trial: 18063500
Drug: glyburide 5
RxNorm normalized name: glyburide 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: glyburide 5 mg b.i.d.
Trial: 9529028
Drug: Granulocyte‐macrophage‐colony stimulating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte‐macrophage‐colony stimulating factor (GM‐CSF) at a dose of 10 microg/kg per day, administered subcutaneously, on a 14‐days‐on/14‐days‐off schedule
Trial: 9529028
Drug: Pentoxifylline (PTX)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PTX) at a dose of 400 mg administered orally 4 times per day
Trial: 7977546
Drug: Intravenous oxytocin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous oxytocin, 20 U
Trial: 27174580
Drug: Premeal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Premeal insulin
Trial: 21144709
Drug: Oral piroxicam
RxNorm normalized name: Piroxicam
DrugBank: Piroxicam (DB00554)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral piroxicam 20mg
Trial: 18499605
Drug: Low-dose sevoflurane
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose sevoflurane inhalation (0.5-1 vol % end-tidal concentration in oxygen 50 vol %)
Trial: 12752022
Drug: Short cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short cognitive-behavioral group treatment
Trial: 2715552
Drug: LY171883 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY171883 (400 mg)
Trial: 324270
Drug: Methylcellulose (Celevac)
RxNorm normalized name: Methylcellulose
DrugBank: Methylcellulose (DB11228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylcellulose (Celevac) - two tablets daily
Trial: 324270
Drug: Placebo -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo - two tablets daily
Trial: 324270
Drug: Methylcellulose (Celevac)
RxNorm normalized name: Methylcellulose
DrugBank: Methylcellulose (DB11228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylcellulose (Celevac) - two tablets daily (crossover group)
Trial: 23061994
Drug: Lidocaine gel
RxNorm normalized name: LIDOCAINE 4 g in 100 g EXTRACORPOREAL PATCH [Arthcal 4% Lidocaine Gel Patches]
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine gel
Trial: 24435717
Drug: Preventive medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive medication action at the time of an office visit
Trial: 9809926
Drug: Carvedilol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (10 mg twice a day)
Trial: 11268711
Drug: Atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 20 mg for 24 weeks
Trial: 9822940
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg three times daily)
Trial: 8130042
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine 20 ml
Trial: 23370149
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (n=39) received 0.1 ml of purified Vero cell rabies vaccine (PVRV) intradermally on days 0 and 21.
Trial: 23370149
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (n=16) received 0.5 ml of PVRV intramuscularly on days 0, 7, and 21.
Trial: 19268499
Drug: Placebo (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (intravenous administration)
Trial: 19268499
Drug: Allopregnanolone (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopregnanolone (intravenous administration)
Trial: 16903602
Drug: Routine acupuncture
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine acupuncture therapy with motor therapy
Trial: 16516010
Drug: Antimuscarinic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimuscarinic therapy
Trial: 10501823
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid supplementation of 200 mg p.o. per day
Trial: 8568117
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (0.5 g twice daily)
Trial: 7192117
Drug: Sulfamethoxydiazine administered
RxNorm normalized name: sulfamethoxypyridazine
DrugBank: Sulfamethoxypyridazine (DB13773)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfamethoxydiazine administered with a test meal
Trial: 7192117
Drug: Sulfamethoxydiazine administered
RxNorm normalized name: sulfamethoxypyridazine
DrugBank: Sulfamethoxypyridazine (DB13773)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfamethoxydiazine administered with a high-lipid meal
Trial: 7192117
Drug: Sulfamethoxydiazine administered
RxNorm normalized name: sulfamethoxypyridazine
DrugBank: Sulfamethoxypyridazine (DB13773)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfamethoxydiazine administered with high-protein or high-carbohydrate meals
Trial: 24257657
Drug: Intravenous tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous tranexamic acid (Group 3)
Trial: 11348938
Drug: Inhaled formoterol
RxNorm normalized name: formoterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled formoterol dry powder, 12 microg bid, in addition to ipratropium bromide, 40 microg qid for 3 weeks
Trial: 2015175
Drug: Soluble ibuprofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soluble ibuprofen 400 mg
Trial: 11215153
Drug: Zopiclone (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone (7.5 mg)
Trial: 11301565
Drug: Nitrazepam (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrazepam (5 mg)
Trial: 26310877
Drug: High-dose nicotine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose nicotine dermal patches (n=90)
Trial: 26310877
Drug: Low-dose nicotine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose nicotine dermal patches (n=132)
Trial: 26310877
Drug: First-generation antipsychotics
RxNorm normalized name: benzethonium chloride / lidocaine hydrochloride Topical Gel [Tecnu First Aid]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First-generation antipsychotics (n=129)
Trial: 26310877
Drug: Preparation stage
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation stage (n=97)
Trial: 25367823
Drug: Composite intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Composite intervention consisting of education on recommended GWG according to IOM, application of personalised weight graph, formalised prescription of exercise and regular monitoring of GWG at every antenatal visit.
Trial: 23551662
Drug: Low-level light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level light therapy (LLLT) device
Trial: 15827107
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (250 mg)